Article Details

Flexion Therapeutics (NASDAQ:FLXN) Lowered to "Sell" at Zacks Investment Research

Retrieved on: 2021-01-23 02:58:28

Tags for this article:

Click the tags to see associated articles and topics

Flexion Therapeutics (NASDAQ:FLXN) Lowered to "Sell" at Zacks Investment Research. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,274,797 shares of the specialty pharmaceutical company's stock valued at $29,913,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up